The Acinetobacter baumannii group:a systemic review

BACKGROUND:The Acinetobacter baumannii group,including Acinetobacter baumannii,Acinetobacter genomospecies 3 and 13 TU,is phenotypically indistinguishable and uniformly identified as Acinetobacter baumannii by laboratories of clinical microbiology.This review aimed to demonstrate the differences amo...

Full description

Saved in:
Bibliographic Details
Published in:World journal of emergency medicine 2013-01, Vol.4 (3), p.169-174
Main Authors: Zhang, Hua-zhong, Zhang, Jin-song, Qiao, Li
Format: Article
Language:English
Subjects:
Antimicrobial agents
Deoxyribonucleic acid
DNA
Drug resistance
Genes
Identification
Infections
Laboratories
Mortality
Multivariate analysis
Pneumonia
Review
Surveillance
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND:The Acinetobacter baumannii group,including Acinetobacter baumannii,Acinetobacter genomospecies 3 and 13 TU,is phenotypically indistinguishable and uniformly identified as Acinetobacter baumannii by laboratories of clinical microbiology.This review aimed to demonstrate the differences among them.METHODS:Literatures associated with the Acinetobacter baumannii group were identified and selected from PubMed databases and relevant journals.RESULTS:Acinetobacter genospecies 3 and 13 TU possess a certain proportion in clinical isolates.There were considerable differences in epidemiologic features,clinical manifestations,antimicrobial resistances and therapeutic options among the Acinetobacter baumannii group.Compared with Acinetobacter genomospecies 3 and 13 TU,Acinetobacter baumannii with a higher resistance to antimicrobial agents are easier to be treated inappropriately,and present a worse outcome in patients.CONCLUSION:The Acinetobacter baumannii group comprises three distinct clinical entities,and their clinical value are not equal.
ISSN:1920-8642
DOI:10.5847/wjem.j.issn.1920-8642.2013.03.002